Elite Laboratories, Inc.
46 drugs in NADAC|46 Generic,0 Brand
Elite Laboratories, Inc. lists 46 NDCs in the CMS NADAC file (46 generic, 0 brand), at an average NADAC of $0.78 per unit, with a week-over-week move of -0.3% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
46
46G / 0B
Avg Price / Unit
$0.7777
$0.07 – $2.70
Avg 7d Change
-0.25%
Across 46 drugs with changes
7d Activity
of 46 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
lisdexamfetamine dimesylate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Central Nervous System Stimulant therapeutic class
Review the broader class where Elite Laboratories, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Elite Laboratories, Inc. make?
Elite Laboratories, Inc. lists 46 NDCs in the CMS NADAC file — 46 generic and 0 brand products.
What is the average price of Elite Laboratories, Inc. drugs?
The average NADAC across Elite Laboratories, Inc.'s portfolio is $0.7777 per unit, ranging from $0.0727 to $2.7009.
What types of drugs does Elite Laboratories, Inc. make?
Elite Laboratories, Inc. makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are Central Nervous System Stimulant (59), Opioid Agonist (10), Sympathomimetic Amine Anorectic (4), Skeletal Muscle Relaxant (3), Dihydropyridine Calcium Channel Blocker (2).
Has Elite Laboratories, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Elite Laboratories, Inc. in the openFDA feed.
How has Elite Laboratories, Inc.'s pricing changed recently?
Over the past 7 days, 20 Elite Laboratories, Inc. products rose and 26 fell, with a portfolio-wide average change of -0.3%.